Skip to main content
Premium Trial:

Request an Annual Quote

Aussie Life Science Distributor to Oversee CombiMatrix s Japanese Subsidiary

NEW YORK, Jan. 26 (GenomeWeb News) - CombiMatrix has transferred to partner INBIO the day-to-day operational responsibility and majority ownership of its Japanese subsidiary, CombiMatrix KK, and has expanded its distribution agreement with INBIO to include Japan, CombiMatrix parent Acacia Research said today.

As part of the deal, INBIO, which is based in Australia, has obtained 67 percent of the voting interests in the KK subsidiary, which is based in Tokyo. "INBIO will assume all operational and financial responsibilities of the KK including its liabilities," Acacia said.

 

The CombiMatrix group will manage new business and strategic relationships and opportunities from its USheadquarters in Mukilteo, Wash.The KK unit and INBIO will "focus exclusively on sales of the CombiMatrix group's products and services," Acacia added.

"The experience of INBIO executives in the Japanese markets as well as their proximity will enable more efficient management of our now jointly owned Japanese subsidiary," Amit Kumar, president and CEO of CombiMatrix, said in a statement.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.